M-PsyC Research
Embedded in a major research university, M-PsyC is committed to responsible, rigorous, multidisciplinary research on psychedelic drugs and the psychedelic experience.
Indeed, M-PsyC was motivated, in part, by cutting-edge research performed by University of Michigan faculty and students, ranging from endogenous synthesis of DMT in neurons, to the neural dynamics of nitrous oxide in primate cortex, to the neural correlates of the Shamanic state of consciousness in humans. We are also committed to research that spans the translational spectrum, from foundational discovery to clinical implementation. This is reflected in the engagement of M-PsyC participants from basic science to clinical care as well as partnerships with the Center for Drug Repurposing and Michigan Institute for Clinical & Health Research, both resources for translational science at the University of Michigan.
Participate in Our Research: Now Recruiting Subjects
The Mood Disorders Lab at University of Michigan is now recruiting subjects for COMP006, a multicenter, randomized, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two initial administrations of COMP360 in participants with treatment-resistant depression (TRD). This study is a Phase 3 multisite study with COMPASS Pathways, Ltd. looking into efficacy and safety of synthetic Psilocybin for TRD. Those interested in receiving additional information on the study may contact:
- Study Coordinator – Josh Saunders-Lustick, (734) 232-0011, josaunde@med.umich.edu
- Study Coordinator – Megan Rush, (734) 232-0207, megjrush@med.umich.edu
- General Lab Contact – (734) 232-0196, depression-research@med.umich.edu
Recent Publications
The following are a sampling of recent work by M-PsyC investigators:
